Safety of co-administration of herbal and conventional medicines on liver and kidney function in stroke patients: A single-center retrospective study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sang-Hwa | - |
dc.contributor.author | Kim, Seo-Young | - |
dc.contributor.author | Yang, Seung-Bo | - |
dc.contributor.author | Jin, Chul | - |
dc.contributor.author | Kwon, Seungwon | - |
dc.contributor.author | Cho, Seung-Yeon | - |
dc.contributor.author | Park, Seong-Uk | - |
dc.contributor.author | Jung, Woo-Sang | - |
dc.contributor.author | Moon, Sang-Kwan | - |
dc.contributor.author | Park, Jung-Mi | - |
dc.contributor.author | Ko, Chang-Nam | - |
dc.date.available | 2021-02-03T23:40:31Z | - |
dc.date.created | 2021-01-20 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 0944-7113 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79891 | - |
dc.description.abstract | Background: Although herbal medicines (HMs) are widely used worldwide, information concerning their interactions with conventional medicines (CMs) is sparse. In particular, stroke affects a high proportion of elderly people with impaired hepatic and renal function. Stroke is often accompanied by various complications and is commonly treated via the co-administration of HMs and CMs in Asia. Purpose: We aimed to investigate the effects of co-administration of HMs and CMs on liver and kidney function in patients with stroke. We estimated the prevalence of drug-induced liver injury (DILI) or herb-induced liver injury (HILI) and drug-induced acute kidney injury (DIAKI) or herb-induced acute kidney injury (HIAKI) in patients co-administered HMs and CMs. Study design: This was a retrospective study that reviewed the electronic medical records of 401 patients with stroke in a single hospital. Methods: The prevalence of DILI or HILI and types of liver injury was examined according to abnormal increases in liver tests. The probable causality between drug or herb administration and liver injury was assessed using the Roussel Uclaf Causality Assessment Method. In addition, the prevalence of DIAKI or HIAKI was estimated using the Kidney Disease Improving Global Outcomes acute kidney injury stage criteria and related medical records. Results: Out of a total of 401 patients, only four (1.0%) developed liver injury. Two cases of DILI (0.5%) and two cases of HILI (0.5%) were reported. Moxifloxacin and ebastine were the CMs that caused hepatotoxicity. Chungpyesagan-tang and Yeoldahanso-tang were the HMs that caused liver toxicity. Even in cases showing severe liver damage, alkaline phosphatase levels remained less than five times the normal value, and liver function test values recovered within 14 days. There were no cases of DIAKI or HIAKI in this cohort. Conclusion: These results suggest that if appropriately prescribed by experts, the co-administration of CMs and HMs is safe and does not adversely affect liver and kidney function in patients with stroke. To support these results, further large-scale multicenter prospective studies and toxicological studies based on the interaction between HMs and CMs are warranted. © 2020 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Elsevier GmbH | - |
dc.relation.isPartOf | Phytomedicine | - |
dc.title | Safety of co-administration of herbal and conventional medicines on liver and kidney function in stroke patients: A single-center retrospective study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000605579700028 | - |
dc.identifier.doi | 10.1016/j.phymed.2020.153435 | - |
dc.identifier.bibliographicCitation | Phytomedicine, v.81 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85097908559 | - |
dc.citation.title | Phytomedicine | - |
dc.citation.volume | 81 | - |
dc.contributor.affiliatedAuthor | Yang, Seung-Bo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | drug-induced acute kidney injury | - |
dc.subject.keywordAuthor | drug-induced liver injury | - |
dc.subject.keywordAuthor | herb-induced acute kidney injury | - |
dc.subject.keywordAuthor | herb-induced liver injury | - |
dc.subject.keywordAuthor | stroke | - |
dc.subject.keywordPlus | acetylsalicylic acid | - |
dc.subject.keywordPlus | alanine aminotransferase | - |
dc.subject.keywordPlus | alkaline phosphatase | - |
dc.subject.keywordPlus | amlodipine | - |
dc.subject.keywordPlus | aspartate aminotransferase | - |
dc.subject.keywordPlus | atorvastatin | - |
dc.subject.keywordPlus | barium sulfate | - |
dc.subject.keywordPlus | bilirubin | - |
dc.subject.keywordPlus | chungpyesagan tang | - |
dc.subject.keywordPlus | clopidogrel | - |
dc.subject.keywordPlus | creatinine | - |
dc.subject.keywordPlus | ebastine | - |
dc.subject.keywordPlus | gamma glutamyltransferase | - |
dc.subject.keywordPlus | glycyrrhizae radix | - |
dc.subject.keywordPlus | herbaceous agent | - |
dc.subject.keywordPlus | metformin | - |
dc.subject.keywordPlus | moxifloxacin | - |
dc.subject.keywordPlus | olmesartan | - |
dc.subject.keywordPlus | radix bupleuri | - |
dc.subject.keywordPlus | radix paeoniae alba | - |
dc.subject.keywordPlus | ranitidine | - |
dc.subject.keywordPlus | rebamipide | - |
dc.subject.keywordPlus | Scutellariae radix | - |
dc.subject.keywordPlus | sodium | - |
dc.subject.keywordPlus | tamsulosin | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | yeoldahanso tang | - |
dc.subject.keywordPlus | acute kidney failure | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | alanine aminotransferase blood level | - |
dc.subject.keywordPlus | alkaline phosphatase blood level | - |
dc.subject.keywordPlus | allopathy | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | aspartate aminotransferase blood level | - |
dc.subject.keywordPlus | bilirubin blood level | - |
dc.subject.keywordPlus | cerebrovascular accident | - |
dc.subject.keywordPlus | Cnidium | - |
dc.subject.keywordPlus | cohort analysis | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | creatinine blood level | - |
dc.subject.keywordPlus | drug combination | - |
dc.subject.keywordPlus | drug safety | - |
dc.subject.keywordPlus | electronic medical record | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | gamma glutamyl transferase blood level | - |
dc.subject.keywordPlus | ginseng | - |
dc.subject.keywordPlus | herbal medicine | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | kidney function | - |
dc.subject.keywordPlus | kidney injury | - |
dc.subject.keywordPlus | liver function | - |
dc.subject.keywordPlus | liver function test | - |
dc.subject.keywordPlus | liver toxicity | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | medical record review | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | normal value | - |
dc.subject.keywordPlus | Poria | - |
dc.subject.keywordPlus | prescription | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | sodium blood level | - |
dc.subject.keywordPlus | stroke patient | - |
dc.subject.keywordPlus | toxic hepatitis | - |
dc.subject.keywordPlus | urea nitrogen blood level | - |
dc.subject.keywordPlus | very elderly | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.